| EPA026 | Characterizing the effect of intracellular storage pools of RANTES/CCL5 on HIV infection in macrophages | E-poster | Innate immunity (including NK cells) |
| EPA027 | HIV-1 Vpu limits Fc-mediated effector functions in vivo | E-poster | Humoral immunity (including broadly neutralizing antibodies), Antibodies and B cells |
| EPA028 | Metabolic gene profiling of activated, terminally differentiated effector memory and exhausted CD8+ T cells in people living with HIV | E-poster | Cellular immunity; T cell vaccines |
| EPA029 | BNT162b2 vaccine elicits impaired B cell and CD8 T cell responses combined with skewed CD4 T responses in patients receiving hemodialysis | E-poster | Cellular immunity; T cell vaccines |
| EPA030 | HIV-1-specific T-cells in an HIV-1-infected but HIV-1 antibody negative patient on long-term antiretroviral therapy | E-poster | Cellular immunity; T cell vaccines |
| EPA031 | Pomalidomide drives expansion of HIV-specific CD8+ T cells and enhances NK cell cytotoxicity to augment anti-HIV immunity | E-poster | Cellular immunity; T cell vaccines |
| EPA032 | Virtual memory CD8+ T-cells exhibit highly cytotoxic profiles in people with HIV, and are expanded by N-803 | E-poster | Cellular immunity; T cell vaccines |
| EPA033 | Persistent dysregulation of Vδ1 T lymphocytes in ART-suppressed people living with HIV | E-poster | Cellular immunity; T cell vaccines |
| EPA034 | Characterization of tissue-resident CD8 T-cells in the pulmonary mucosa of people living with HIV on long-term ART | E-poster | Mucosal immunity |
| EPA035 | HIV clade C gp140-SIV-Gag/Nef protein vaccine adjuvanted with NE/AS01B enhanced antibody-mediated effector function and reduced viral loads in SHIV-infected macaques | E-poster | Mucosal immunity |